首页> 外文OA文献 >PRM23 - MODELLING CANCER TREATMENTS IN THE ADJUVANT SETTING: A TARGETED LITERATURE REVIEW (TLR) OF TECHNOLOGY APPRAISALS (TA) OF ADJUVANT THERAPIES SUBMITTED TO THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) AND A CASE STUDY IN ADJUVANT MELANOMA.

【2h】

PRM23 - MODELLING CANCER TREATMENTS IN THE ADJUVANT SETTING: A TARGETED LITERATURE REVIEW (TLR) OF TECHNOLOGY APPRAISALS (TA) OF ADJUVANT THERAPIES SUBMITTED TO THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) AND A CASE STUDY IN ADJUVANT MELANOMA.

机译：PRM23 - 在佐剂环境中建模癌症治疗：佐剂治疗技术评估（TA）的有针对性的文献综述（TLR）提交给国家卫生和护理卓越研究所（尼斯）和佐剂黑色素瘤的案例研究。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
R Batteson; M Hemstock; R Hart; O Saunders; S Kotapati; KM Gooden; A Amadi;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Fewer fractions of adjuvant external beam radiotherapy for early breast cancer are safe and effective and can now be the standard of care. Why the UK's NICE accepts fewer fractions as the standard of care for adjuvant radiotherapy in early breast cancer. [J] . Harnett A The Breast : . 2010,第3期

机译：早期乳腺癌辅助外照射放疗的几分之几是安全有效的，现在可以成为护理标准。为什么英国的NICE接受较少的分数作为早期乳腺癌辅助放疗的护理标准。
2. Selection of Optimal Adjuvant Chemotherapy Regimens for Early Breast Cancer and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Cancer Care Ontario Clinical Practice Guideline Summary [J] . Neelima Denduluri, Mark R. Somerfield, Antonio C. Wolff Journal of Oncology Practice . 2016,第5期

机译：早期乳腺癌最佳辅助化疗方案的选择以及HER2阳性乳腺癌的辅助靶向治疗：美国临床肿瘤学协会癌症适应指南安大略临床实践指南摘要
3. Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature. [J] . Alam N, Shepherd FA, Winton T, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2005,第3期

机译：非小细胞肺癌术后辅助化疗的依从性。分析了加拿大国家癌症研究所和小组间试验JBR.10，并对文献进行了回顾。
4. Simulation modeling as an aid to decision-making in healthcare management: the Adjuvant Breast Cancer (ABC) trial [C] . Baldwin, L.P., Eldabi, . 1999

机译：模拟模型可帮助医疗保健管理决策：辅助乳腺癌（ABC）试验
5. Enabling the use of individualized information at point of care: A tailored, quantitative decision aid for breast cancer adjuvant therapy. [D] . Byers, Angela Kwan Yee Hung. 2005

机译：能够在护理时使用个性化信息：乳腺癌辅助治疗的量身定制的定量决策辅助工具。
6. The use of UK primary care databases in health technology assessments carried out by the National Institute for health and care excellence (NICE) [O] . Thomas P. Leahy, Sreeram Ramagopalan, Cormac Sammon 2020

机译：美国卫生技术评估中的英国初级保健数据库在国家健康和护理卓越研究所（尼斯）进行
7. NI1 RETROSPECTIVE ANALYSIS OF TECHNOLOGY APPRAISALS CONDUCTED BY UK'S NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE (NICE) IN SEVERAL CANCER INDICATIONS: HIGHER EVIDENCE BARRIERS FOR TARGETED THERAPIES? [O] . Banerji L, Das S 2010

机译：英国国家卫生与临床卓越研究院（NICE）对几种癌症适应症进行技术评估的NI1回顾性分析：针对性靶向疗法的证据证据更高？

PRM23 - MODELLING CANCER TREATMENTS IN THE ADJUVANT SETTING: A TARGETED LITERATURE REVIEW (TLR) OF TECHNOLOGY APPRAISALS (TA) OF ADJUVANT THERAPIES SUBMITTED TO THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) AND A CASE STUDY IN ADJUVANT MELANOMA.

著录项

引文网络

相似文献

相关主题

期刊订阅